Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries
- PMID: 18729183
- DOI: 10.1002/ijc.23798
Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries
Abstract
The objective of the study was to assess the risk of second primary cancers (SPCs) following a primary head and neck cancer (oral cavity, pharynx and larynx) and the risk of head and neck cancer as a SPC. The present investigation is a multicenter study from 13 population-based cancer registries. The study population involved 99,257 patients with a first primary head and neck cancer and contributed 489,855 person-years of follow-up. To assess the excess risk of SPCs following head and neck cancers, we calculated standardized incidence ratios (SIRs) by dividing the observed numbers of SPCs by the expected number of cancers calculated from accumulated person-years and the age-, sex- and calendar period-specific first primary cancer incidence rates in each of the cancer registries. During the observation period, there were 10,826 cases of SPCs after head and neck cancer. For all cancer sites combined, the SIR of SPCs was 1.86 (95% CI = 1.83-1.90) and the 20-year cumulative risk was 36%. Lung cancer contributed to the highest proportion of the SPCs with a 20-year cumulative risk of 13%. Excess second head and neck cancer risk was observed 10 years after diagnosis with lymphohaematopoietic cancers. The most common SPC following a first primary head and neck cancer was lung cancer. However, the highest excess of SPCs was in the head and neck region. These patterns were consistent with the notion that the pattern of cancer in survivors of head and neck cancer is dominated by the effect of tobacco smoking and alcohol drinking.
(c) 2008 Wiley-Liss, Inc.
Similar articles
-
Italian cancer figures, report 2013: Multiple tumours.Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. Epidemiol Prev. 2013. PMID: 24259384 English, Italian.
-
Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1543-9. doi: 10.1158/1055-9965.EPI-07-2876. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559572
-
Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.Oral Oncol. 2013 Jan;49(1):9-14. doi: 10.1016/j.oraloncology.2012.06.018. Epub 2012 Jul 26. Oral Oncol. 2013. PMID: 22840787
-
[Incidence and risk factors of second primary cancers in patients treated for primary pharyngeal cancer].Bull Cancer Radiother. 1996;83(1):8-11. Bull Cancer Radiother. 1996. PMID: 8679284 Review. French.
-
Risk of second primary cancer in patients with head and neck squamous cell carcinoma: a systemic review and meta-analysis.Clin Oral Investig. 2023 Sep;27(9):4897-4910. doi: 10.1007/s00784-023-05066-3. Epub 2023 Aug 4. Clin Oral Investig. 2023. PMID: 37540282 Review.
Cited by
-
Urine Phthalate Metabolites are Elevated in Patients with Esophageal Squamous Cell Carcinoma and Associated with Advanced Cancer Stage and Poor Survival.Cancer Manag Res. 2024 Aug 1;16:989-1001. doi: 10.2147/CMAR.S469007. eCollection 2024. Cancer Manag Res. 2024. PMID: 39108298 Free PMC article.
-
Exploring tonsillar cancer associations in patients with base of tongue cancer: insights from a single-center study.Eur Arch Otorhinolaryngol. 2024 Nov;281(11):5955-5959. doi: 10.1007/s00405-024-08830-7. Epub 2024 Jul 23. Eur Arch Otorhinolaryngol. 2024. PMID: 39042171 Free PMC article.
-
Locally Advanced Laryngeal Squamous cell Carcinoma in a Patient with a Synchronous Second Primary Thyroid Carcinoma.Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3906-3909. doi: 10.1007/s12070-023-03968-y. Epub 2023 Jun 16. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37974801
-
Oral Complications from Oropharyngeal Cancer Therapy.Cancers (Basel). 2023 Sep 14;15(18):4548. doi: 10.3390/cancers15184548. Cancers (Basel). 2023. PMID: 37760517 Free PMC article. Review.
-
Incidence of second primary cancers in oral and pharyngeal cancer patients using a large medical claims database in Japan.J Dent Sci. 2023 Jul;18(3):1047-1054. doi: 10.1016/j.jds.2022.11.025. Epub 2022 Dec 9. J Dent Sci. 2023. PMID: 37404617 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
